KZR Kezar Life Sciences, Inc.

Fundamentals / CIK 0001645666 / USD

Kezar Life Sciences, Inc. reported $0 in revenue and a net loss of $45.23M for the fiscal year ended December 31, 2025.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KZR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$17.66M$8.83M$0-$95.84MFY 2016 Net Income: -$8.99M2016FY 2017 Net Income: -$8.52M2017FY 2018 Net Income: -$23.17M2018FY 2019 Net Income: -$35.09M2019FY 2020 Net Income: -$41.74M2020FY 2021 Revenue: $0FY 2021 Net Income: -$54.63M2021FY 2022 Revenue: $0FY 2022 Net Income: -$68.24M2022FY 2023 Revenue: $7.00MFY 2023 Net Income: -$101.9M2023FY 2024 Revenue: $0FY 2024 Net Income: -$83.74M2024FY 2025 Revenue: $0FY 2025 Net Income: -$56.03M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $7.00M $0 $0 -- -- -- -- --
Research & Development $33.76M $65.74M $85.70M $51.01M $38.94M $30.98M $27.36M $18.14M $6.47M $7.37M
Total Operating Expenses $59.11M $90.61M $118.4M $71.16M $54.66M $42.95M $37.34M $24.73M $8.75M $8.99M
Operating Income -$59.11M -$90.61M -$111.4M -$71.16M -$54.66M -$42.95M -$37.34M -$24.73M -$8.75M -$8.99M
EBITDA -$58.21M -$89.56M -$110.4M -$70.14M -$53.15M -$41.41M -$36.04M -$24.04M -$8.57M -$8.84M
Interest Income $4.44M $8.46M $11.10M $4.11M -- -- -- -- -- --
Interest Expense -- $1.59M $1.55M $1.19M $159K $0 -- -- -- --
Income Before Tax -$56.03M -$83.74M -$101.9M -- -- -- -- -- -- --
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$56.03M -$83.74M -$101.9M -$68.24M -$54.63M -$41.74M -$35.09M -$23.17M -$8.52M -$8.99M
Basic EPS -$7.66 -$11.49 -$14.04 -$10.13 -$10.40 -$9.50 -$18.40 -$22.60 -$142.10 -$265.60
Diluted EPS -$7.66 -$11.49 -$14.04 -$10.13 -$10.40 -$9.50 -$18.40 -$22.60 -$142.10 -$265.60
Basic Shares Outstanding 7.3M 7.3M 7.3M 6.7M 5.3M 4.4M 1.9M 1.0M 59.9K 33.8K
Diluted Shares Outstanding 7.3M 7.3M 7.3M 6.7M 5.3M 4.4M 1.9M 1.0M 59.9K 33.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue -- -- -- -- -- -- $0 --
Research & Development $1.54M $5.08M $6.91M $9.58M $12.18M $16.03M $16.24M $16.30M
Total Operating Expenses $7.37M $15.16M $11.71M $14.60M $17.63M $21.56M $21.95M $23.38M
Operating Income -$7.37M -$15.16M -$11.71M -$14.60M -$17.63M -$21.56M -$21.95M -$23.38M
EBITDA -$7.32M -$14.99M -$11.49M -$14.36M -$17.38M -$21.30M -$21.69M -$23.12M
Interest Income $609K $801K $1.03M $1.20M $1.42M $1.73M $2.04M $2.24M
Interest Expense $0 -- -- $302K $347K -- $403K $401K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$5.76M -$14.55M -$11.23M -$13.70M -$16.56M -$20.22M -$20.31M -$21.55M
Basic EPS -$0.78 -- -$1.53 -$1.87 -$2.27 -- -$2.78 -$2.96
Diluted EPS -$0.78 -- -$1.53 -$1.87 -$2.27 -- -$2.78 -$2.96
Basic Shares Outstanding 7.3M -- 7.3M 7.3M 7.3M -- 7.3M 7.3M
Diluted Shares Outstanding 7.3M -- 7.3M 7.3M 7.3M -- 7.3M 7.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $71.88M $41.75M $35.49M $40.46M $62.88M $21.23M $14.95M $24.18M $51.03M
Short-Term Investments $0 $90.50M $165.9M $236.1M $145.5M $119.2M $63.26M $83.25M --
Cash & Short-Term Investments $71.88M $132.2M $201.4M $276.6M $208.4M $140.4M $78.21M $107.4M $51.03M
Accounts Receivable, Net -- -- -- $0 -- -- -- -- --
Other Current Assets -- -- -- $920K $729K $1.63M $1.05M $489K $508K
Total Current Assets $75.73M $137.5M $206.9M $285.7M $211.7M $144.8M $81.13M $109.8M $52.33M
Property, Plant & Equipment, Net $166K $2.89M $3.91M $3.43M $3.28M $3.44M $4.28M $4.59M $1.54M
Other Non-Current Assets $0 $2.42M $5.59M $674K $282K $282K $282K $282K $343K
Total Non-Current Assets $915K $7.19M $14.29M $13.85M $6.28M $7.03M $8.38M $4.88M $1.90M
Total Assets $76.65M $144.7M $221.2M $299.6M $217.9M $151.8M $89.51M $114.7M $54.22M
Accounts Payable $507K $3.65M $8.25M $2.48M $2.03M $2.36M $823K $193K $547K
Short-Term Debt $0 $5.22M $0 -- -- -- -- -- --
Other Current Liabilities -- -- -- -- -- $21K $62K $112K $26K
Total Current Liabilities $6.57M $20.33M $17.74M $11.00M $8.21M $6.44M $6.00M $3.34M $1.48M
Long-Term Debt $0 $5.11M $10.07M $9.83M $9.62M -- -- -- --
Total Non-Current Liabilities $0 $7.44M $15.92M $18.70M $12.85M $4.42M $5.46M $2.55M $494K
Total Liabilities $6.57M $27.77M $33.66M $29.70M $21.06M $10.86M $11.47M $5.88M $1.98M
Total Debt (incl. Leases) $2.33M $16.18M $18.93M $21.26M $14.04M $5.46M $6.36M -- --
Common Stock $7.0K $7.0K $7.0K $68K $56K $46K $19K $19K $1.0K
Retained Earnings -$490.5M -$434.5M -$350.8M -$248.9M -$180.7M -$126.0M -$84.28M -$49.20M -$26.03M
Accumulated Other Comp. Income $0 -$162K -$130K -$923K -$291K -$137K -$196K -$203K -$111K
Total Stockholders' Equity $70.07M $116.9M $187.6M $269.9M $196.9M $141.0M $78.05M $108.8M -$25.69M
Total Equity $70.07M $116.9M $187.6M $269.9M $196.9M $141.0M $78.05M $108.8M -$25.69M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $66.23M $71.88M $38.94M $34.37M $37.00M $41.75M $34.86M $28.28M
Short-Term Investments -- $0 $51.28M $66.48M $77.36M $90.50M $113.5M $135.9M
Cash & Short-Term Investments $66.23M $71.88M $90.22M $100.8M $114.4M $132.2M $148.4M $164.2M
Total Current Assets $67.56M $75.73M $94.50M $104.7M $120.3M $137.5M $156.4M $167.6M
Property, Plant & Equipment, Net $0 $166K $2.17M $2.41M $2.65M $2.89M $3.15M $3.39M
Other Non-Current Assets -- $0 $0 $674K $674K $2.42M $2.42M $6.52M
Total Non-Current Assets $436K $915K $3.23M $4.42M $4.94M $7.19M $7.71M $12.30M
Total Assets $68.00M $76.65M $97.73M $109.1M $125.3M $144.7M $164.1M $179.9M
Accounts Payable $273K $507K $911K $1.16M $1.97M $3.65M $3.46M $2.26M
Short-Term Debt -- $0 $5.28M $5.29M $5.22M $5.22M $3.91M $2.61M
Total Current Liabilities $2.76M $6.57M $13.38M $14.37M $16.96M $20.33M $20.43M $17.50M
Long-Term Debt -- $0 $1.37M $2.63M $3.87M $5.11M $6.35M $7.59M
Total Non-Current Liabilities $0 $0 $1.37M $2.97M $5.23M $7.44M $9.61M $11.74M
Total Liabilities $2.76M $6.57M $14.75M $17.34M $22.19M $27.77M $30.04M $29.24M
Total Debt (incl. Leases) $1.35M $2.33M $9.91M $12.07M $14.11M $16.18M $16.91M $17.61M
Common Stock $7.0K $7.0K $7.0K $7.0K $7.0K $7.0K $7.0K $73K
Retained Earnings -$496.3M -$490.5M -$476.0M -$464.8M -$451.1M -$434.5M -$414.3M -$394.0M
Accumulated Other Comp. Income $0 $0 $14K -$267K -$232K -$162K $107K -$385K
Total Stockholders' Equity $65.24M $70.07M $82.98M $91.79M $103.1M $116.9M $134.0M $150.7M
Total Equity $65.24M $70.07M $82.98M $91.79M $103.1M $116.9M $134.0M $150.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$56.03M -$83.74M -$101.9M -$68.24M -$54.63M -$41.74M -$35.09M -$23.17M -$8.52M -$8.99M
Depreciation & Amortization $897K $1.04M $1.07M $1.02M $1.51M $1.54M $1.30M $690K $175K $154K
Stock-Based Compensation $8.96M $13.01M $18.14M $14.01M $7.60M $4.94M $4.01M $1.99M $203K $128K
Operating Cash Flow -$51.78M -$74.21M -$81.64M -$58.85M -$42.44M -$36.95M -$29.88M -$20.79M -$8.11M -$9.76M
Capital Expenditure -$8.0K -$29K -$1.81M -$1.58M -$316K -$194K -$607K -$1.12M -$389K -$132K
Free Cash Flow -$51.78M -$74.24M -$83.45M -$60.42M -$42.75M -$37.14M -$30.48M -$21.91M -$8.50M -$9.89M
Purchases of Investments -$42.63M -$91.34M -$180.4M -$332.2M -$156.4M -$225.7M -$102.3M -$119.2M -- --
Investing Cash Flow $92.46M $80.43M $76.05M -$91.39M -$28.44M -$56.50M $20.42M -$83.90M -$389K -$132K
Common Stock Issued -- -- -- -- -- -- -- $77.69M -- --
Dividends Paid $0 $0 $0 $0 $0 $0 $0 $0 -- --
Financing Cash Flow -$10.59M $103K $638K $127.9M $112.6M $99.64M $272K $77.91M $49.76M $36K
Net Change in Cash $30.13M $6.26M -$4.96M -$22.43M $41.65M $6.28M -$9.23M -$26.86M $41.29M -$10.01M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income -$5.76M -$14.55M -$11.23M -$13.70M -$16.56M -$20.22M -$20.31M -$21.55M
Depreciation & Amortization $47K $176K $227K $243K $251K $259K $260K $261K
Stock-Based Compensation $653K $1.63M $2.14M $2.42M $2.78M $3.31M $3.19M $3.08M
Operating Cash Flow -$7.45M -$11.96M -$9.83M -$12.79M -$17.19M -$16.82M -$17.49M -$17.03M
Capital Expenditure $0 $0 $0 $0 -$8.0K -$11K -$18K $0
Free Cash Flow -$7.45M -$11.96M -$9.83M -$12.79M -$17.20M -$16.84M -$17.51M -$17.03M
Purchases of Investments -- $0 -$14.30M -$28.33M $0 -$19.23M -$19.98M -$34.78M
Investing Cash Flow $1.53M $51.61M $15.71M $11.40M $13.74M $23.74M $24.06M $12.22M
Dividends Paid $0 $0 $0 $0 $0 $0 $0 $0
Financing Cash Flow $267K -$6.71M -$1.30M -$1.27M -$1.30M $47K $0 $56K
Net Change in Cash -$5.65M $32.94M $4.57M -$2.63M -$4.75M $6.89M $6.58M -$4.76M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -1591.8% -- -- -- -- -- -- --
Net Profit Margin -- -- -1455.3% -- -- -- -- -- -- --
Return on Equity (ROE) -80.0% -71.6% -54.3% -25.3% -27.7% -29.6% -45.0% -21.3% -- --
Return on Assets (ROA) -73.1% -57.9% -46.0% -22.8% -25.1% -27.5% -39.2% -20.2% -15.7% --
Current Ratio 11.52x 6.76x 11.66x 25.98x 25.77x 22.48x 13.52x 32.91x 35.26x --
Quick Ratio 10.93x 6.51x 11.35x 25.15x 25.37x 21.80x 13.03x 32.19x 34.39x --
Debt to Equity 0.03x 0.14x 0.10x 0.08x 0.07x 0.04x 0.08x -- -- --
Revenue Growth (YoY) -- -100.0% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Return on Equity (ROE) -69.3% -80.0% -74.4% -77.1% -76.3% -71.6% -71.4% -65.4%
Return on Assets (ROA) -66.5% -73.1% -63.1% -64.9% -62.8% -57.9% -58.4% -54.8%
Current Ratio 24.46x 11.52x 7.06x 7.29x 7.09x 6.76x 7.65x 9.58x
Quick Ratio 23.98x 10.93x 6.74x 7.02x 6.74x 6.51x 7.26x 9.38x
Debt to Equity 0.02x 0.03x 0.12x 0.13x 0.14x 0.14x 0.13x 0.12x
Revenue Growth (YoY) -- -- -- -- -- -- -100.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001645666) · from December 31, 2016 Data through March 31, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal